The MCF7/TAMR-7 Cell line is a breast cancer cell line resistant to tamoxifen. The MCF7/TAMR-7 cell line is a good model cell to study the signalling pathways, which are the major drivers of tamoxifen-resistant growth.
| Inventor | Institute |
|---|---|
| Anne Lykkesfeldt | Danish Cancer Society, Denmark |
| SKU: | 152087 |
|---|---|
| Product description: | The MCF7/TAMR-7 Cell line is a breast cancer cell line resistant to tamoxifen. The MCF7/TAMR-7 cell line is a good model cell to study the signalling pathways, which are the major drivers of tamoxifen-resistant growth. |
| Alternate name: | MCF-7/TAMR-7; TAMR-7 |
| Gender: | Female |
| Conditional: | Yes |
| Production details: | The parental cell line for the MCF7/TAMR-7 cells is MCF7/S0.5, which was adapted to grow at low serum concentration in order to study the effect of estradiol and tamoxifen. MCF7/TAMR-7 has been established from a clone of cells that survived long term treatment with 1 uM tamoxifen. Tamoxifen-resistant cells are passaged continuously in presence of 1 uM tamoxifen, which is lethal for the parental MCF7/S0.5 cell line. |
| Cellosaurus ID: | CVCL_1D43 |
| Parental cell line: | MCF7 S0.5 |
| Disease: | Cancer |
| Cat. #: | 152087 |
|---|---|
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Breast cancer |
| Research Fields: | Cancer; Drug development |
| Organism: | Human |
| Tissue: | Breast |
| Gender: | Female |
| Model: | Tumour line |
| Cancer Types In Detail: | Breast cancer;Tamoxifen resistant |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | Phenol red-free DMEM:Ham’s F-12 containing 1% fetal bovine serum, 2 mM Glutamax and 6 ng/ml insulin. To maintain high-level resistance, medium was supplemented with Tamoxifen (1 uM). |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Recommended controls: | MCF7-S0.5 parental line |
| References: |
Hole et al. 2015. Int J Oncol. 46(4):1481-1490. PMID: 25625755. Elias et al. 2015. Oncogene. 34(15):1919-1927. PMID: 24882577. Pedersen et al. 2014. Int J Oncol. 45(5):2167-2175. PMID: 25175082. Lundqvist et al. 2014. Steroids. 85:30-35. PMID: 24747771. Thrane et al. 2013. Breast Cancer Res Treat. 139(1):71-80. PMID: 23609470. Larsen et al. 2012. Int J Oncol. 41(5):1863-1870. PMID: 22961366. Frankel et al. 2007. Breast Cancer Res Treat. 104(2):165-179. PMID: 17061041. Berstein et al. 2003. Endocr Relat Cancer. 10(2):267-277. PMID: 12790788. |
|---|
MCF7/TAMR-7 Cell Line. Mid log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC)
MCF7/TAMR-7 Cell Line. Late log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC)
MCF7/TAMR-7 Cell Line. Early log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC).



| Cat. # | Tool Name | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152086 | MCF7/TAMR-8 Cell Line |
Key Info
MCF7/TAMR-8 Cell Line
|
View Tool | |||||||||||
| 152088 | MCF7/TAMR-4 Cell Line |
Key Info
MCF7/TAMR-4 Cell Line
|
View Tool | |||||||||||
| 152089 | MCF7/TAMR-1 Cell Line |
Key Info
MCF7/TAMR-1 Cell Line
|
View Tool | |||||||||||
| 152090 | MCF7/S0.5 Cell Line |
Key Info
MCF7/S0.5 Cell Line
|
View Tool | |||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.